Back to Top Skip to main content

Influenza Seasonal

Visit the 2019-2020 Seasonal Influenza Resource Center

Take the 2019-2020 Seasonal Influenza Vaccination Training

Flu disease picture  Influenza is a highly contagious viral infection. There are three main antigen types of influenza: types A, B, and C. Influenza type A causes moderate to severe illness and affects all age groups. Type A can infect both humans and animals. The notion that influenza type B generally causes milder disease than type A has been recently challenged and is more fatal in children. Type B mainly infects humans. Influenza type C only causes mild respiratory illness. Influenza activity peaks from December to March in the Northern Hemisphere.

Influenza is transmitted from person to person mainly when an infected person coughs or sneezes. Transmission can also occur from direct contact with respiratory secretions, such as when touching surfaces contaminated with influenza virus and then touching the eyes, nose, or mouth, or from indirect contact with droplets from coughs or sneezes. Transmission can occur from the day before symptoms begin until about 5 days after symptoms begin in adults, or up to 10 days or more after symptoms begin in children.

About 50% of infected persons will develop "classic" influenza disease. This is characterized by the abrupt onset of fever, muscle pain, sore throat, nonproductive cough, runny nose, and headache. These symptoms generally last from 2 to 3 days. However, some people may experience a loss of strength or energy for several weeks. In addition, some people may develop complications, such as pneumonia.

Source: Centers for Disease Control and Prevention

You also may be interested in...

2018-2019 COAST GUARD OIX ANNUAL INFLUENZA (FLU) IMMUNIZATION PROGRAM

Policy

Coast Guard medical guidance for the 2018-19 influenza season and its influenza immunization program.

Guidance for the 2018-2019 Annual Influenza Immunization Program

Policy

ASD(HA) memo detailing the forthcoming immunization requirements for the 2018-19 influenza season.

ALARACT 2017-2018 INFLUENZA PREVENTION PROGRAM - SURVEILLANCE AND VACCINATION

Policy

ALARACT on the 2017-18 Influenza Prevention Program.

  • Identification #: ALARACT 099/2017
  • Date: 11/15/2017
  • Type: Instructions
  • Topics: Influenza Seasonal

2017-2018 NAVY INFLUENZA VACCINATION AND REPORTING POLICY

Policy

U.S. Navy influenza immunization policy for the 2017-18 influenza season.

Air Force 2017-2018 Seasonal Influenza Vaccination Program Implementation Plan

Policy

Air Force policy and resources for the 2017-18 Seasonal Influenza Vaccination Program.

USEUCOM GENADMIN 2017-18 Influenza (Flu) Prevention and Control

Policy

Guidance for use of the 2017-18 seasonal influenza vaccine in the U.S. European Command.

DoD Guidance for the 2017-2018 Annual Influenza Immunization Program

Policy

DoD Guidance for the 2017-2018 Annual Influenza Immunization Program

Policy

A memo from the Assistant Secretary of Defense for Health Affairs detailing the DoD immunization policy for the 2017-18 influenza season.

Seasonal Flu Prevention and Protection for the Federal Workforce

Policy

This memorandum encourages all federal employees to get a flu shot.

MARADMIN 2016-17 SEASONAL INFLUENZA VACCINE GUIDANCE FOR ACTIVE AND RESERVE COMPONENTS

Policy
  • Identification #: MARADMIN 501/16
  • Date: 9/22/2016
  • Type: Instructions
  • Topics: Influenza Seasonal

Air Force 2016-2017 Seasonal Influenza Vaccination Program Guidance

Policy

DoDEA Influenza Vaccine Requirement

Policy

I MEF 2016-17 ANNUAL INFLUENZA VACCINE GUIDANCE

Policy

ALCOAST 2016-2017 ANNUAL INFLUENZA IMMUNIZATION PROGRAM

Policy

BUMED 2016 2017 SEASONAL INFLUENZA MESSAGE

Policy
<< < 1 2 > >> 
Showing results 1 - 15 Page 1 of 2

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing; Download a PDF Reader or learn more about PDFs.